HOME >> MEDICINE >> NEWS
Should we help to create disabled babies?

Should genetic tests be offered to couples seeking to have a child to allow them to select for disability? Many would see deliberately creating disabled babies as the most perverse manifestation of creating designer babies but, in this week's BMJ, Julian Savulescu argues that there may be good reasons for acceding to such requests.

We offer genetic tests to couples to allow them to select the child from the possible children they could have with the best opportunity of having the best life. But how should we decide what constitutes "the best life prospects?"

Each couple makes its own decision about whether or not to have a child with Down's syndrome. "But my value judgement should not be imposed on couples who must bear and rear the child. Nor should the value judgement of doctors, politicians, or the state be imposed directly or indirectly (through the denial of services) on them," he says.

There are good reasons to engage people in dialogue about their decisions, to try to persuade them with arguments, but in the end we should respect their decisions about their own lives.

Reproduction should be about having children who have the best prospects, but we must give individual couples the freedom to act on their own value judgement of what constitutes a life of prospect. That includes the freedom to do what others disapprove of or judge wrong, provided the exercise of freedom does not harm others, he writes.

As rational people, we should all form our own ideas about what is the best life. But to know what is the good life and impose this on others is at best overconfidence at worst, arrogance, he concludes.


'"/>

Contact: Emma Wilkinson
ewilkinson@bmj.com
44-207-383-6529
BMJ-British Medical Journal
3-Oct-2002


Page: 1

Related medicine news :

1. Should medical students have earlier contact with patients?
2. Should nurses conduct breast cancer follow-up visits?
3. Should compulsory screening of immigrants be part of UK public health policy?
4. Should the standard guidelines for assessing prostate cancer control be changed?
5. Should living liver donation be available in the NHS?
6. Should ambulance crews perform emergency breathing procedure?
7. C-reactive proteins: Should everyone be tested?
8. Should people with dementia be electronically tagged?
9. Should people with diabetes sleep with the lights on?
10. Should women be screened for domestic violence?
11. Should banks be liable for pollution caused by companies that borrow from them?

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/9/2016)... (PRWEB) , ... February 09, 2016 , ... Steven Douglas ... Taste of South Florida Event, an upscale fundraiser held in South Florida. The Inaugural ... and guests alike. This year the event will be held in a new, more ...
(Date:2/9/2016)... ... February 09, 2016 , ... URise Products announces ... mobility device, the StandUp Walker. Made entirely in the USA, the StandUp Walker ... years. , StandUp Walker’s novel patent-pending design offers 2-in-1 benefits of a ...
(Date:2/9/2016)... ... February 09, 2016 , ... BioPlus ... the continuation of the ‘Pay It Forward’ program into 2016. BioPlus partners with ... our specialty pharmacy. , “Since our Pay It Forward program began, we ...
(Date:2/9/2016)... Milwaukee, WI (PRWEB) , ... February 09, 2016 ... ... Bon-Ton, Bergner’s, Boston Store, Carson’s, Elder-Beerman, Herberger’s and Younkers department stores, announced it ... Medical College of Wisconsin Cancer Center, Holden Comprehensive Cancer Center at the University ...
(Date:2/9/2016)... Florida (PRWEB) , ... February 09, 2016 , ... ... cold therapy products, announced today the introduction of the newly designed, innovative shoulder ... comfort and better cold therapy coverage for the injured arm and shoulder to ...
Breaking Medicine News(10 mins):
(Date:2/9/2016)...  Sangamo BioSciences, Inc. (NASDAQ: SGMO ), ... its fourth quarter and full year 2015 financial ... therapeutic genome editing," said Edward Lanphier, Sangamo,s president ... (ZFN) technology leads the therapeutic genome editing field ... to move our ground-breaking genome editing programs through ...
(Date:2/9/2016)... -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) today announced ... full year financial results on Tuesday, February 23, 2016, ... will host a live audio webcast immediately following the ... fourth quarter and full year 2015 financial results and ... 2016 financial results. www.jazzpharmaceuticals.com .  Please connect ...
(Date:2/9/2016)... Sciences Ltd. (NYSE:  AXON), a leading clinical-stage biopharmaceutical ... announced further details of three new clinical trials ... Lewy body dementia, a disease affecting approximately 1.4 ... the three studies were recently initiated and the ... In addition, the Company reported financial results for ...
Breaking Medicine Technology:
Cached News: